Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-04-22 @ 8:03 AM
Study NCT ID:
NCT02498418
Status:
COMPLETED
Last Update Posted:
2019-12-05
First Post:
2015-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea
Sponsor:
Actavis Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-09
First Submit QC Date:
None
Study First Post Date:
2015-07-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-11-01
Results First Submit QC Date:
None
Results First Post Date:
2019-12-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-03
Last Update Post Date:
2019-12-05
Last Update Post Date Type:
ACTUAL